Alessandra Magnani
Investigador
Research group
Professional network profiles
Last Publications
- Riller Q, Fourgeaud J, Bruneau J, De Ravin SS, Smith G, Fusaro M, Meriem S, Magerus A, Luka M, Abdessalem G, Lhermitte L, Jamet A, Six E, Magnani A, Castelle M, Lévy R, Lecuit MM, Fournier B, Winter S, Semeraro M, Pinto G, Abid H, Mahlaoui N, Cheikh N, Florkin B, Frange P, Jeziorski E, Suarez F, Sarrot-Reynauld F, Nouar D, Debray D, Lacaille F, Picard C, Pérot P, Regnault B, Da Rocha N, de Cevins C, Delage L, Pérot BP, Vinit A, Carbone F, Brunaud C, Marchais M, Stolzenberg MC, Asnafi V, Molina T, Rieux-Laucat F, Notarangelo LD, Pittaluga S, Jais JP, Moshous D, Blanche S, Malech H, Eloit M, Cavazzana M, Fischer A, Ménager MM and Neven B Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 151(6): 1634-1645.
- Sobrino S, Magnani A, Semeraro M, Martignetti L, Cortal A, Denis A, Couzin C, Picard C, Bustamante J, Magrin E, Joseph L, Roudaut C, Gabrion A, Soheili T, Cordier C, Lortholary O, Lefrere F, Rieux-Laucat F, Casanova JL, Bodard S, Boddaert N, Thrasher AJ, Touzot F, Taque S, Suarez F, Marcais A, Guilloux A, Lagresle-Peyrou C, Galy A, Rausell A, Blanche S, Cavazzana M and Six E Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy CELL REPORTS MEDICINE . 4(2): 100919-100919.
- Forcade E, Bacquet S, Ballot C, Capin L, Garnier F, Giraud C, Guérout-Vérité MA, Letellier C, Magnani A, Mamez AC, Nasone J, Sinayoko M, Baudoux E, Mialou V, Yakoub-Agha I and Calmels B Method and impact of allografts cryopreservation during the Covid-19 pandemic: Guidelines from the SFGM-TC BULLETIN DU CANCER . 110(2): 39-47.
Projects
- Project name:
- Ensayo clínico fase Ib multicéntrico, exploratorio, abierto, no-aleatorizado y prospectivo, basket trial, con células CAR-T anti-CD19 (ARI-0001) en pacientes pediátricos con enfermedades autoinmunes sistémicas.
- Leader
- Jordi Antón López, Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI25/00025
- Starting - finishing date:
- 2026 - 2029
- Project name:
- ADVANCED THERAPIES (RICORS-TERAV)
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- RD24/0014/0006
- Starting - finishing date:
- 2025 - 2027
- Project name:
- Desarrollo de una nueva terapia génica para curar la deficiencia de CMH de clase II
- Leader
- Alessandra Magnani
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI24/00424
- Starting - finishing date:
- 2025 - 2027
